Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy Subjects

NCT06876623 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Bioequivalence of Dabigatran Etexilate Mesylate Capsules From Two Different Manufacturers in Healthy Chinese Subjects

Interventions

DRUG: dabigatran etexilate mesylate capsules 150mg

Sponsor

The Affiliated Hospital Of Guizhou Medical University